Radioimmunoassay for Type I Procollagen in Growth Hormone-deficient Children before and during Treatment with Growth Hormone

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Pediatric Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1203/00006450-198501000-00003PMID 3969319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth hormone treatment for short stature.

  1983cited by this paper
• Collagen fibril formation during embryogenesis.

  1983cited by this paper
• Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.

  1981cited by this paper
• Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin.

  1981cited by this paper
• Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.

  1980cited by this paper
• POSTNATAL DEVELOPMENT OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM /RAAS/ IN RELATION TO ELECTROLYTE BALANCE IN PREMATURE INFANTS

  1979cited by this paper
• Antigenic relatedness of primate procollagens as determined by a competitive radioimmunoassay.

  1978cited by this paper
• Purification and characterization of a peptide from the carboxy-terminal region of chick tendon procollagen type I.

  1977cited by this paper
• Renal Functions of Low Birth Weight Infants during the First Two Months of Life

  1977cited by this paper
• Radioimmunoassay of Procollagen in Serum of Patients with Paget's Disease of Bone

  1976cited by this paper
• Radioimmunoassay for Human Procollagen

  1974cited by this paper
• Isolation of a disulfide-stabilized, three-chain polypeptide fragment unique to the precursor of human collagen.

  1973cited by this paper
• The relationship between electrolyte and acid-base balance in the premature infant during early postnatal life.

  1971cited by this paper
• Collagen-Like Fragments: Excretion in Urine of Patients with Paget's Disease of Bone

  1967cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Assessing accuracy of testing and diagnosis in cystic fibrosis

  2023cites this paper
• THE AMINO-TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN IN GROWTH HORMONE-DEFICIENT PATIENTS DURING TRANSITION PERIOD

  2016cites this paper
• Effect of Growth Hormone on Growth Bone loss Induced by Supraphysiologic Glucocorticoid in Rats

  2006cites this paper
• Estrogen regulation of growth hormone action.

  2004cites this paper
• Pubertal Changes in Biochemical Markers of Growth

  2003cites this paper
• Growth Hormone and Insulin-like Growth Factor-I Treatment for Metabolic Bone Diseases

  2002cites this paper
• Osteoporosis and the Growth Hormone-Insulin-Like Growth Factor Axis

  2002cites this paper
• Combined Effects of Estrogen and Progesterone on the Anterior Cruciate Ligament

  2001cites this paper
• CHAPTER 79 – Growth Hormone and Insulin-Like Growth Factors: Potential Applications and Limitations in the Management of Osteoporosis

  2001cites this paper
• Dynamics of bone turnover in children with GH deficiency treated with GH until final height.

  2000cites this paper
• Potential Biochemical Growth Markers in Premature Infants

  1999cites this paper
• TYPE I AND III PROCOLLAGEN PROPEPTIDES IN SARCOIDOSIS, FIBROSING ALVEOLITIS AND ASBESTOS- RELATED LUNG DISEASES

  1999cites this paper
• Effect of growth hormone on growth failure and bone loss induced by supraphysiologic dose of glucocorticoid in rats.

  1999cites this paper
• Effect of estrogen on cellular metabolism of the human anterior cruciate ligament.

  1999cites this paper
• Potential biochemical growth markers in premature infants.

  1999cites this paper
• MARKERS OF COLLAGEN METABOLISM IN THE ASSESSMENT OF RHEUMATOID ARTHRITIS.

  1999cites this paper
• Intestinal Calcium Absorption and Bone Metabolism in Young Adult Men with Childhood‐Onset Growth Hormone Deficiency

  1998cites this paper
• Growth hormone, skin and wound healing--experimental studies in the rat.

  1997cites this paper
• Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.

  1997cites this paper
• Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.

  1997cites this paper
• Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels

  1997cites this paper
• Growth Hormone, Skin and Wound Healing—experimental studies in the rat

  1997cites this paper
• Peptídeos derivados do colágeno: novos marcadores bioquímicos do metabolismo ósseo

  1997cites this paper
• Collagen metabolites in the prediction of response to GH therapy in short children.

  1997cites this paper
• Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis.

  1996cites this paper
• Serum type I and type III procollagen peptide levels in sarcoidosis.

  1996cites this paper
• The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.

  1996cites this paper
• Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.

  1996cites this paper
• Sex steroid regulation of growth hormone secretion and action.

  1996cites this paper
• The changes in serum type I and III procollagen, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with chronic renal failure.

  1996cites this paper
• Extracellular matrix 1: Fibril-forming collagens.

  1995cites this paper
• Growth Hormone Economy in Hypogonadism: Effects of Sex Steroids

  1995cites this paper
• Carboxy‐terminal propeptide of human type I collagen and pyridinium cross‐links as markers of bone growth in infants 1 to 18 months of age

  1995cites this paper
• Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.

  1995cites this paper
• Evaluation of recombinant human growth hormone for wound management.

  1995cites this paper
• Post-traumatic dynamic change of carboxyterminal propeptide of type I procollagen, alkaline phosphatase and its isoenzymes as predictors for enhanced osteogenesis in patients with severe head injury

  1994cites this paper
• Twenty-four-Hour Osteocalcin, Carboxyterminal Propeptide of Type I Procollagen, and Aminoterminal Propeptide of Type III Procollagen Rhythms in Normal and Growth-Retarded Children

  1994cites this paper
• Episodic changes of serum procollagen type I carboxy-terminal propeptide levels in fertile and postmenopausal women.

  1994cites this paper
• Bone Formation Markers and Pain Palliation in Bone Metastases Treated with Strontium‐89

  1994cites this paper
• Extracellular matrix. 1: fibril-forming collagens.

  1994cites this paper
• The insulin-like growth factor axis and collagen turnover during prednisolone treatment.

  1994cites this paper
• Serum concentrations of procollagen I C‐terminal propeptide, osteocalcin and insulin‐like growth factor‐I in patients with non‐lethal osteogenesis irnperfecta

  1993cites this paper
• Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.

  1993cites this paper
• Serum levels of bone GLA protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegly: Effects of long-term octreotide treatment

  1993cites this paper
• Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.

  1993cites this paper
• Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.

  1993cites this paper
• Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.

  1993cites this paper
• Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.

  1993cites this paper
• Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease

  1992cites this paper
• Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.

  1992cites this paper
• Collagen Types I and III Propeptides as Markers of Healing in Chronic Leg Ulcers A Noninvasive Method for the Determination of Procollagen Propeptides in Wound Fluid—Influence of Growth Hormone

  1992cites this paper
• Impact of short‐term estrogen administration on growth hormone secretion and action: Distinct route‐dependent effects on connective and bone tissue metabolism

  1992cites this paper
• Evaluation of growth hormone secretion and treatment.

  1992cites this paper
• Procollagen type I C-terminal extension peptide in predialysis chronic renal failure.

  1992cites this paper
• Topical Human Growth Hormone Treatment of Chronic Leg Ulcers

  1991cites this paper
• Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease.

  1991cites this paper
• Carboxyterminal propeptide of type I procollagen in cerebrospinal fluid in childhood and in children with leukemia undergoing intrathecal treatment.

  1991cites this paper
• Serum Concentrations of the Type I and III Procollagen Propeptides as Biochemical Markers of Growth Velocity in Healthy Infants and Children and in Children with Growth Disorders

  1991cites this paper
• Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH.

  1991cites this paper
• Human growth hormone replacement therapy: pharmacological and clinical aspects.

  1991cites this paper
• GH-replacement therapy in adults.

  1991cites this paper
• Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases.

  1990cites this paper
• Radioimmunoassayof the CarboxyterminalPropeptideof HumanType I Procollagen

  1990cites this paper
• Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

  1990cites this paper
• Collagen Markers in Clinical Work

  1989cites this paper
• Longitudinal Assessment of Type I Procollagen in Children with Inflammatory Bowel Disease Subjected to Surgery

  1989cites this paper
• Growth hormone influences collagen deposition and mechanical strength of intact rat skin. A dose-response study.

  1989cites this paper
• Clinical Tests As Predictors of Growth Response in GH Treatment of Short Normal Children

  1989cites this paper
• Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.

  1989cites this paper
• Long-Term Monitoring of Treatment with Recombinant Human Growth Hormone by Serial Determinations of Type III Procollagen-Related Antigens in Serum

  1988cites this paper
• Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease.

  1988cites this paper
• Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.

  1988cites this paper
• Procollagen type I carboxy‐terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase

  1987cites this paper
• Growth and phosphorus metabolism in premature infants fed human milk, fortified human milk, or special premature formula. Use of serum procollagen as a marker of growth.

  1987cites this paper
• Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel disease.

  1986cites this paper
• The carboxyl fragment released by bacterial collagenase from human type I procollagen: antibodies to the propeptide determinants.

  1985cites this paper